Gå direkt till innehåll

Mediearkiv

Lokon Pharma develops cutting edge immunotherapeutics

Lokon Pharma AB is a Swedish biotech company developing tumor microenvironment (TME) gene engineering vectors aiming to cause tumor stroma inflammation and subsequent anti-tumor immunity.

Lokon Pharma AB
Bredgränd 14
753 20 Uppsala
Sverige